| # | Drug | Count |
|---|---|---|
| 0 | SILDENAFIL CITRATE | 1280 |
| 1 | ADALIMUMAB | 1086 |
| 2 | METHOTREXATE SODIUM | 978 |
| 3 | METHOTREXATE | 857 |
| 4 | INFLIXIMAB | 814 |
| 5 | ETANERCEPT | 808 |
| 6 | TADALAFIL | 759 |
| 7 | PREDNISONE | 714 |
| 8 | ASPIRIN | 502 |
| 9 | ASPIRIN 325 MG | 478 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TALIMOGENE LAHERPAREPVEC | 69 | 0.0435 |
| 1 | DABRAFENIB | 439 | 0.0207 |
| 2 | TRAMETINIB | 435 | 0.0179 |
| 3 | GOLIMUMAB | 184 | 0.0146 |
| 4 | INFLIXIMAB-DYYB | 50 | 0.0145 |
| 5 | ERGOCALCIFEROL | 395 | 0.0133 |
| 6 | VEMURAFENIB | 131 | 0.0109 |
| 7 | SILDENAFIL CITRATE | 1280 | 0.0100 |
| 8 | TADALAFIL | 759 | 0.0075 |
| 9 | FINGOLIMOD HYDROCHLORIDE | 38 | 0.0075 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 1983 |
| 1 | Corticosteroid [EPC] | 1356 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1114 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 862 |
| 4 | Phosphodiesterase 5 Inhibitor [EPC] | 771 |
| 5 | Vitamin C [EPC] | 636 |
| 6 | Interleukin-23 Antagonist [EPC] | 588 |
| 7 | Kinase Inhibitor [EPC] | 563 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 522 |
| 9 | Vitamin B12 [EPC] | 522 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 28 | 0.0407 |
| 1 | Provitamin D2 Compound [EPC] | 395 | 0.0133 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 66 | 0.0113 |
| 3 | Lymphocyte Growth Factor [EPC] | 11 | 0.0087 |
| 4 | Interleukin-17A Antagonist [EPC] | 255 | 0.0068 |
| 5 | Guanylate Cyclase-C Agonist [EPC] | 13 | 0.0063 |
| 6 | Phosphodiesterase 5 Inhibitor [EPC] | 771 | 0.0057 |
| 7 | Interleukin-23 Antagonist [EPC] | 588 | 0.0056 |
| 8 | Integrin Receptor Antagonist [EPC] | 411 | 0.0047 |
| 9 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 64 | 0.0046 |